Merck snags Elanco's coccidiosis treatment for $55 millionFebruary 20, 2020Elanco Animal Health has unloaded its proprietary oral drench treatment for coccidiosis in calves and lambs to Merck Animal Health in an all-cash deal totaling $55 million.
SPONSORED CONTENTLife Gets Busy, Stay ON POINT With Cytopoint®Simplify your approach to allergic pruritus with Cytopoint. Help maintain control of allergic itch when schedules get hectic for both veterinarians and pet owners alike. + Learn more
AAVMC, Merck division unite on AMR projectDecember 10, 2019The Association of American Veterinary Medical Colleges (AAVMC) has joined forces with MSD Animal Health, a division of Merck & Co., on an international grant program designed to mitigate global health concerns surrounding antimicrobial resistance (AMR).